Travere Therapeutics TVTX
NASDAQ TVTX
$51.99 +0.36 (+0.70%)
At close: Nov 10, 2026 · 4:00 PM EST

Travere Therapeutics (TVTX) Shares Outstanding (2009 - 2026)

Updated

Travere Therapeutics' Weighted Average Shares Outstanding came in at 94.63 million for Q3 2026, up 6.0% from 89.23 million a year earlier and up 1.2% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Shares Outstanding (2009 - 2026) Analysis & Trends

For FY2025, Travere Therapeutics' Weighted Average Shares Outstanding was 89.21 million, up 13.1% from FY2024.

  • Weighted Average Shares Outstanding has increased in each of the last 13 years, with a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
  • Going back by year, Weighted Average Shares Outstanding was 78.89 million in FY2024 (+6.2%), 74.27 million in FY2023 (+16.5%), 63.76 million in FY2022 (+6.6%) and 59.83 million in FY2021 (+25.9%).
  • The Q3 2026 figure represents the highest quarterly Weighted Average Shares Outstanding in data going back to Q4 2011.
  • Year-over-year, Weighted Average Shares Outstanding has increased for 52 consecutive quarters, with growth averaging 9.8% over the last eight quarters.
  • Across the past five years, year-over-year growth in Weighted Average Shares Outstanding ran from 1.9% in Q3 2024 to 25.9% in Q4 2021.
  • Business Quant data shows TVTX's Weighted Average Shares Outstanding at 93.48 million (Q2 2026), 91.87 million (Q1 2026) and 89.21 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.94 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.55 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.24 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.70 Bn
10 Travere Therapeutics 4.97 Bn 4.56 Bn 221.70 Mn 94.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 94.63 Mn
Jun 30, 2026 93.48 Mn
Mar 31, 2026 91.87 Mn
Dec 31, 2025 89.21 Mn
Sep 30, 2025 89.23 Mn
Jun 30, 2025 88.95 Mn
Mar 31, 2025 88.36 Mn
Dec 31, 2024 78.89 Mn
Sep 30, 2024 77.78 Mn
Jun 30, 2024 77.50 Mn
Mar 31, 2024 77.14 Mn
Dec 31, 2023 74.27 Mn
Sep 30, 2023 76.31 Mn
Jun 30, 2023 76.00 Mn
Mar 31, 2023 68.17 Mn
Dec 31, 2022 63.76 Mn
Sep 30, 2022 64.03 Mn
Jun 30, 2022 63.64 Mn
Mar 31, 2022 63.13 Mn
Dec 31, 2021 59.83 Mn
API Access

Travere Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=TVTX&period=max&api_key=YOUR_API_KEY